Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
Exosomes co-encapsulating antigen and immunoadjuvants act as an effective therapeutic cancer vaccine
Date
2021-08-01
Author
Yildirim, Muzaffer
Yildirim, Tugce Canavar
Gucluler, Gozde
Bayyurt Kocabaş, Banu
Kahraman, Tamer
Evcili, Irem
Kaya, G. Gokberk
Bozbeyoglu, Naz
Yagci, Fuat Cem
Gursel, Ihsan
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
211
views
0
downloads
Cite This
Subject Keywords
Adjuvants and vaccines
,
anti-cancer vaccine
,
immunotherapy
,
in vivo tumor models
URI
https://hdl.handle.net/11511/99010
Journal
EUROPEAN JOURNAL OF IMMUNOLOGY
Collections
Department of Biology, Article
Suggestions
OpenMETU
Core
Forging a potent vaccine adjuvant: CpG ODN/cationic peptide nanorings
Gungor, Bilgi; Yagci, Fuat Cem; GÜRSEL, İHSAN; Gürsel, Mayda (2014-07-01)
Type I interferon inducers may potentially be engineered to function as antiviral and anticancer agents, or alternatively, vaccine adjuvants, all of which may have clinical applications. We recently described a simple strategy to convert a Toll-like receptor 9 (TLR9) agonist devoid of interferon alpha (IFN alpha) stimulating activity into a robust Type I interferon inducer with potent vaccine adjuvant activity.
Exact solutions and the consistency of 3D minimal massive gravity
Altas, Emel; Tekin, Bayram (2015-07-20)
We show that all algebraic type-O, type-N and type-D and some Kundt-type solutions of topologically massive gravity are inherited by its holographically well-defined deformation, that is, the recently found minimal massive gravity. This construction provides a large class of constant scalar curvature solutions to the theory. We also study the consistency of the field equations both in the source-free and matter-coupled cases. Since the field equations of MMG do not come from a Lagrangian that depends on the...
Ion-exchange studies with several complex ions.
Türkmen, Baylan R; Department of Physics (1973)
Multiscale tumor modeling
Ünsal, Serbülent; Acar, Aybar Can; Department of Health Informatics (2014)
Cancer’s complex behavior decreases success rates of the cancer therapies. The usual steps cancer therapy are, deciding phase of the cancer and planing the therapy according to medical guidelines and there is no room or chance for personalized medicine. Simulation systems that use patient specific data as input and up-to-date scientific evidence as business rules has chance to help clinicians for evidence based personalized medicine practice.In this study our aim is creating a basic model to guide researche...
Uncertainty modelling and stability analysis for 2-way fuzzy adaptive systems
Gürkan, Evren; Erkmen, Aydan Müşerref; Banks, Stephen P.; Department of Electrical and Electronics Engineering (2003)
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
M. Yildirim et al., “Exosomes co-encapsulating antigen and immunoadjuvants act as an effective therapeutic cancer vaccine,”
EUROPEAN JOURNAL OF IMMUNOLOGY
, vol. 51, pp. 416–416, 2021, Accessed: 00, 2022. [Online]. Available: https://hdl.handle.net/11511/99010.